Aimo A, Egea OI, Emdin M, Bayes-Genis A, et al. Overlapping Effects of miR-21 Inhibition and Drugs for Idiopathic Pulmonary Fibrosis: Rationale for Repurposing Nintedanib as a Novel Treatment for Ischemia/Reperfusion Injury. J Cardiovasc Pharmacol 2021;77:332-333.
PMID: 33394826